Nature of Operations and Summary of Significant Accounting Policies - VIE Income Statement (Details) - USD ($) |
3 Months Ended | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
Variable Interest Entity [Line Items] | ||||||||||
Net income | $ (3,701,698) | $ (2,750,756) | $ (1,886,375) | $ 1,345,898 | $ (862,988) | $ (722,943) | $ 104,020 | $ 2,499,119 | $ (6,992,931) | $ 1,017,208 |
Income from discontinued operations before income tax expense | (3,883,748) | (2,693,562) | (1,719,222) | 1,516,243 | (1,142,713) | (894,990) | 39,258 | 3,383,195 | (6,780,289) | 1,384,750 |
Income tax expense from discontinued operations | $ (182,050) | $ 57,194 | $ 167,153 | $ 170,345 | $ (279,725) | $ (172,047) | $ (64,762) | $ 884,076 | 212,642 | 367,542 |
Corporate Clinics | ||||||||||
Variable Interest Entity [Line Items] | ||||||||||
Net income | (6,992,931) | 1,017,208 | ||||||||
Income tax expense from discontinued operations | 212,642 | 367,542 | ||||||||
Variable Interest Entity | Corporate Clinics | ||||||||||
Variable Interest Entity [Line Items] | ||||||||||
Net income | 1,400,000 | 1,200,000 | ||||||||
Income from discontinued operations before income tax expense | 1,641,325 | 1,505,635 | ||||||||
Income tax expense from discontinued operations | $ 212,642 | $ 310,388 |
X | ||||||||||
- Definition Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|